Comparing Nanovibronix (FEED) & Its Rivals

Nanovibronix (NASDAQ:FEED) is one of 27 publicly-traded companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it weigh in compared to its rivals? We will compare Nanovibronix to similar businesses based on the strength of its valuation, earnings, institutional ownership, dividends, risk, profitability and analyst recommendations.

Insider and Institutional Ownership

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 19.3% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 5.2% of Nanovibronix shares are held by company insiders. Comparatively, 19.9% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Nanovibronix and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$2.56 million	-$3.70 million	-0.04
Nanovibronix Competitors	$62.62 million	-$29.77 million	1.50

Nanovibronix’s rivals have higher revenue, but lower earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Nanovibronix and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
Nanovibronix Competitors	-500.48%	-110.93%	-48.62%

Volatility and Risk

Nanovibronix has a beta of 2.26, meaning that its share price is 126% more volatile than the S&P 500. Comparatively, Nanovibronix’s rivals have a beta of 1.80, meaning that their average share price is 80% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Nanovibronix and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	82	88	199	7	2.35

As a group, “Surgical, Medical, And Dental Instruments And Supplies” companies have a potential upside of 56.31%. Given Nanovibronix’s rivals stronger consensus rating and higher possible upside, analysts clearly believe Nanovibronix has less favorable growth aspects than its rivals.

Summary

Nanovibronix rivals beat Nanovibronix on 8 of the 13 factors compared.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.